Evidence map›Paper›PMID 40270478›Full record

ReviewJournal of internal medicine2025

Gut microbiota development across the lifespan: Disease links and health-promoting interventions.

Ida Schoultz, Marcus J Claesson, Maria Gloria Dominguez-Bello, Frida Fåk Hållenius, Peter Konturek, Katri Korpela, Martin Frederik Laursen, John Penders, H Roager, Tommi Vatanen and 2 more

Abstract readReview
In one paragraph

Review in Journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The impact ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. [Gut microbiota and allergic diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ida SchoultzSchool of Medical Sciences, Faculty of Medicine and Health Örebro University, Orebro, Sweden.ORCID 0000-0002-8391-1576
Marcus J ClaessonSchool of Microbiology and APC Microbiome Ireland, Cork, Ireland.
Maria Gloria Dominguez-BelloDepartment of Biochemistry & Microbiology and of Anthropology, Rutgers University-New Brunswick, New Brunswick, New Jersey, USA.
Frida Fåk HålleniusDepartment of Food Technology, Engineering and Nutrition, Lund University, Lund, Sweden.
Peter KonturekDepartment of Medicine, Thuringia Clinic Saalfeld, Teaching Hospital of the University Jena, Jena, Germany.
Katri KorpelaFaculty of Medicine, University of Helsinki, Helsinki, Finland.
Martin Frederik LaursenNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
John PendersDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
H RoagerDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.
Tommi VatanenInstitute of Biotechnology, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Lena ÖhmanDepartment of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Maria C JenmalmDivision of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0002-2117-5366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota plays a pivotal role in human life and undergoes dynamic changes throughout the human lifespan, from infancy to old age. During our life, the gut microbiota influences health and disease across life stages. This review summarizes the discussions and presentations from the symposium "Gut microbiota development from infancy to old age" held in collaboration with the Journal of Internal Medicine. In early infancy, microbial colonization is shaped by factors such as mode of delivery, antibiotic exposure, and milk-feeding practices, laying the foundation for subsequent increased microbial diversity and maturation. Throughout childhood and adolescence, microbial maturation continues, influencing immune development and metabolic health. In adulthood, the gut microbiota reaches a relatively stable state, influenced by genetics, diet, and lifestyle. Notably, disruptions in gut microbiota composition have been implicated in various inflammatory diseases-including inflammatory bowel disease, Type 1 diabetes, and allergies. Furthermore, emerging evidence suggests a connection between gut dysbiosis and neurodegenerative disorders such as Alzheimer's disease. Understanding the role of the gut microbiota in disease pathogenesis across life stages provides insights into potential therapeutic interventions. Probiotics, prebiotics, and dietary modifications, as well as fecal microbiota transplantation, are being explored as promising strategies to promote a healthy gut microbiota and mitigate disease risks. This review focuses on the gut microbiota's role in infancy, adulthood, and aging, addressing its development, stability, and alterations linked to health and disease across these critical life stages. It outlines future research directions aimed at optimizing the gut microbiota composition to improve health.

Indexed as

AgingGastrointestinal MicrobiomeHealth PromotionAdultChildDysbiosisFecal Microbiota TransplantationHumansInfantPrebioticsProbioticsPrebioticsadulthoodaginggut microbiotainfancyinflammatory diseasesintervention

Identifiers

PMID40270478
PMCPMC12087861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.